⌘K

Home/Filings/4/0001209191-22-049692

4//SEC Filing

Alland Leila 4

Accession 0001209191-22-049692

CIK 0001699382other

View on SEC.gov Company Profile

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 4:23 PM ET

Size

4.8 KB

Accession

0001209191-22-049692

Insider Transaction Report

Form 4

Period: 2022-09-09

PMV Pharmaceuticals, Inc.PMVP

Chief Medical Officer

Transactions

Award
Common Stock
2022-09-09+52,200→ 52,200 total

Footnotes (1)

[F1]The reported shares are represented by restricted stock units, or RSUS. One- third of the RSUs vest on September 9, 2023 and the remaining shares vest on September 9, 2024.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PMV Pharmaceuticals, Inc.

CIK 0001699382

Entity typeother

Related Parties

1

filerCIK 0001825216

Filing Metadata

Form type: 4
Filed: Sep 12, 8:00 PM ET
Accepted: Sep 13, 4:23 PM ET
Size: 4.8 KB

View on SEC.gov